U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515950) titled 'A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER' on March 31.
Brief Summary: The REVEAL-BTC Study will analyze 5 biomarkes in samples of participants who in the past 15 year have been diagnosed with any stage of biliary tract cancer. The expression levels of the biomarkers will be correlated with clinical outcomes in the participants, which will lead to better patient stratification that will help guide the use of targeted therapies in the future.
Study Start Date: July, 2026
Study Type: OBSERVATIONAL
Condition:
Biliary Tract Cancer (BTC)
Intervention:
OTHER: No intervention
Non applicable
Recruitment Status: NO...